Telcagepant
id:
telcagepant-321-12744964
title:
Telcagepant
text:
Telcagepant (INN) is a calcitonin gene-related peptide receptor antagonist which was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. In the acute treatment of migraine, it was found to have equal efficacy to rizatriptan and zolmitriptan. A Phase IIa clinical trial studying telcagepant for the prophylaxis of episodic migraine was stopped on March 26, 2009, after the "identification of two patients with significant elevations in serum transamina
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Telcagepant
date created:
date modified:
2023-10-03T02:14:23Z
main entity:
{"identifier":"Q5675567","url":"https://www.wikidata.org/entity/Q5675567"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a9/Telcagepant_structure.svg","width":512,"height":350}
fields total:
13
integrity:
15